Clinical Trial Update: Relationship Between Efficacy of Lumateperone and Brain Glutamate and Dopamine [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the relationship between lumateperone efficacy and brain glutamate and dopamine in psychosis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychosis

Drugs mentioned

• Lumateperone (lumateperone)

Snippet

Sponsor: University of New Mexico | Conditions: Psychosis | Phase 4 | Status: WITHDRAWN